{
  "items": "50",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Harbor Capital Advisors Inc. Sells 435,043 Shares of AdaptHealth Corp. $AHCO",
      "url": "https://www.marketbeat.com/instant-alerts/filing-harbor-capital-advisors-inc-sells-435043-shares-of-adapthealth-corp-ahco-2025-12-27/",
      "time_published": "20251227T110817",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Harbor Capital Advisors Inc. reduced its stake in AdaptHealth Corp. by 72.9% in the third quarter, selling 435,043 shares and retaining 162,117 shares valued at approximately $1.45 million. Simultaneously, AdaptHealth director David Solomon Williams III sold 5,000 shares, decreasing his holdings by 9.99%. The company's recent earnings missed EPS estimates but exceeded revenue expectations, while analysts hold a consensus \"Hold\" rating with an average target price of $13.60.",
      "banner_image": "https://www.marketbeat.com/logos/adapthealth-corp-logo-1200x675.png?v=20240515085317",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940005"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.826071"
        },
        {
          "topic": "finance",
          "relevance_score": "0.712498"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.605187"
        }
      ],
      "overall_sentiment_score": -0.294637,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.282021",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "3 Reasons to Avoid AHCO and 1 Stock to Buy Instead",
      "url": "https://finviz.com/news/261281/3-reasons-to-avoid-ahco-and-1-stock-to-buy-instead",
      "time_published": "20251222T230200",
      "authors": [
        "Anthony Lee"
      ],
      "summary": "This article recommends avoiding AdaptHealth (AHCO) despite its recent stock gains, citing three primary reasons: lackluster revenue growth, declining earnings per share (EPS), and unimpressive returns on invested capital. Instead, the author suggests looking into alternative high-quality growth stocks, highlighting their curated list which has historically outperformed the market.",
      "banner_image": "https://news-assets.stockstory.org/cover-images/_1400x700_crop_center-center_none/adapthealth-corp-cover-image-3ade57e263c0_2025-01-13-131212_qgzn.jpeg",
      "source": "Finviz",
      "category_within_source": "General",
      "source_domain": "Finviz",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940400"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.828160"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.744768"
        }
      ],
      "overall_sentiment_score": -0.067803,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.400285",
          "ticker_sentiment_label": "Bearish"
        },
        {
          "ticker": "NVDA",
          "relevance_score": "0.620762",
          "ticker_sentiment_score": "0.341189",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Settles Investors\u2019 Revenue Lawsuit for $35 Million",
      "url": "https://news.bloomberglaw.com/business-and-practice/adapthealth-settles-investors-revenue-lawsuit-for-35-million",
      "time_published": "20251222T212400",
      "authors": [
        "Martina Barash"
      ],
      "summary": "AdaptHealth Corp. has agreed to a $35 million settlement in a class-action lawsuit brought by investors. The lawsuit alleged that the company concealed a fraudulent billing scheme and issues with merger integrations. The investors recommended approval of the settlement, citing litigation risks and concerns about AdaptHealth's ability to pay a larger judgment due to insurance limits and financial condition.",
      "banner_image": "https://news-api.bloomberglaw.com/v1/resize-image?url=http%3A%2F%2Fbloomberg-bna-brightspot.s3.amazonaws.com%2F3c%2F6b%2F9c8be37d441a8f25a836cc0268d1%2Fbli-litigation-lawyers.png&width=1240&height=480&fit=cover",
      "source": "Bloomberg Law News",
      "category_within_source": "General",
      "source_domain": "Bloomberg Law News",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.911748"
        }
      ],
      "overall_sentiment_score": -0.372605,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.931010",
          "ticker_sentiment_score": "-0.382828",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth Settles Investors\u2019 Revenue Lawsuit for $35 Million",
      "url": "https://news.bloomberglaw.com/litigation/adapthealth-settles-investors-revenue-lawsuit-for-35-million",
      "time_published": "20251222T210954",
      "authors": [
        "Martina Barash"
      ],
      "summary": "AdaptHealth Corp. has agreed to a $35 million settlement in a class-action lawsuit where investors alleged the company concealed a fraudulent billing scheme and issues with merger integrations. The investors urged the US District Court for the Eastern District of Pennsylvania to approve the settlement, citing litigation risks and concerns about AdaptHealth\u2019s ability to cover a larger judgment due to insurance limits and financial condition. The company had previously settled a separate investor-related matter.",
      "banner_image": "https://news-api.bloomberglaw.com/v1/resize-image?url=http%3A%2F%2Fbloomberg-bna-brightspot.s3.amazonaws.com%2F3c%2F6b%2F9c8be37d441a8f25a836cc0268d1%2Fbli-litigation-lawyers.png&width=1240&height=480&fit=cover",
      "source": "Bloomberg Law News",
      "category_within_source": "General",
      "source_domain": "Bloomberg Law News",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.831508"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.739073"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.626171"
        }
      ],
      "overall_sentiment_score": -0.410116,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.430564",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Responsive Playbooks and the AHCO Inflection",
      "url": "https://news.stocktradersdaily.com/news_release/38/Responsive_Playbooks_and_the_AHCO_Inflection_121825074802_1766105282.html",
      "time_published": "20251218T194800",
      "authors": [
        "Randall S.",
        "Thomas H. Kee Jr."
      ],
      "summary": "This article provides analysis for Adapthealth Corp. (NASDAQ: AHCO), highlighting a neutral near-term sentiment but strong mid-term sentiment that may be stalling. It details three AI-generated trading strategies with specific entry, target, and stop-loss zones for different risk profiles, along with multi-timeframe signal analysis. The report identifies key support and resistance levels for AHCO's stock price.",
      "banner_image": "https://news.stocktradersdaily.com/media/689050_AHCO_graph.jpg",
      "source": "Stock Traders Daily",
      "category_within_source": "General",
      "source_domain": "Stock Traders Daily",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.946086"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.732500"
        }
      ],
      "overall_sentiment_score": 0.048432,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.037204",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp.'s (NASDAQ:AHCO) Price Is Right But Growth Is Lacking",
      "url": "https://news.futunn.com/en/post/66161105/adapthealth-corp-s-nasdaq-ahco-price-is-right-but-growth",
      "time_published": "20251214T040954",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "AdaptHealth Corp. (NASDAQ:AHCO) exhibits a low price-to-sales (P/S) ratio of 0.4x, which suggests it could be a buy compared to the industry average of 1.3x for healthcare companies in the United States. However, this low P/S is attributed to the company's negative recent revenue growth and a forecast of slower growth (4.3%) compared to the industry (6.5%) in the coming year. Investors are thus signaling limited future growth potential for AdaptHealth.",
      "banner_image": "https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20251213/0-e0876a2964d2d0a9e5eee3429dc3b9df-0-7ad5be219e54c179425ecaf9ca867f29.png/big",
      "source": "\u5bcc\u9014\u725b\u725b",
      "category_within_source": "General",
      "source_domain": "\u5bcc\u9014\u725b\u725b",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.911564"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.809975"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.720382"
        }
      ],
      "overall_sentiment_score": -0.257591,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.269591",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth (NASDAQ:AHCO) Trading 8.8% Higher - Time to Buy?",
      "url": "https://www.marketbeat.com/instant-alerts/adapthealth-nasdaqahco-trading-88-higher-time-to-buy-2025-12-10/",
      "time_published": "20251211T010954",
      "authors": [
        "MarketBeat"
      ],
      "summary": "AdaptHealth (NASDAQ:AHCO) shares traded up 8.8% in mid-day trading but with 80% lower than average volume. Analyst opinions on the stock are mixed, with ratings ranging from \"Buy\" to \"Strong Sell\" and a consensus \"Hold\" rating with an average price target of $13.60. Despite missing EPS estimates but beating revenue in its latest quarter, the company's financials show a market cap of $1.39 billion and varied institutional activity.",
      "banner_image": "https://www.marketbeat.com/logos/adapthealth-corp-logo-1200x675.png?v=20240515085317",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.920235"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.801479"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.718045"
        },
        {
          "topic": "finance",
          "relevance_score": "0.649988"
        }
      ],
      "overall_sentiment_score": 0.113863,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.138522",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Understanding the Setup: (AHCO) and Scalable Risk",
      "url": "https://news.stocktradersdaily.com/news_release/16/Understanding_the_Setup:_AHCO_and_Scalable_Risk_120725060202_1765148522.html",
      "time_published": "20251207T180200",
      "authors": [
        "Robert S."
      ],
      "summary": "This article analyzes Adapthealth Corp. (NASDAQ: AHCO), highlighting a weak near-term sentiment and a mid-channel oscillation pattern. It identifies an exceptional 34.3:1 risk-reward setup, targeting an 11.3% gain against 0.3% risk, and outlines three distinct AI-generated trading strategies for different risk profiles. The analysis covers position trading, momentum breakout, and risk hedging strategies, alongside multi-timeframe signal analysis.",
      "banner_image": "https://news.stocktradersdaily.com/media/681096_AHCO_graph.jpg",
      "source": "Stock Traders Daily",
      "category_within_source": "General",
      "source_domain": "Stock Traders Daily",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.918092"
        },
        {
          "topic": "finance",
          "relevance_score": "0.727137"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.618171"
        }
      ],
      "overall_sentiment_score": 0.006488,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.306524",
          "ticker_sentiment_score": "0.012150",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Adapthealth director Williams sells $47k in stock",
      "url": "https://in.investing.com/news/insider-trading-news/adapthealth-director-williams-sells-47k-in-stock-93CH-5141088",
      "time_published": "20251206T053141",
      "authors": [
        "Investing.com"
      ],
      "summary": "AdaptHealth Corp Director David Solomon Williams III sold 5,000 shares of common stock for $47,150 on December 4, 2025. This transaction leaves Williams with 45,045 directly owned shares. The sale follows AdaptHealth's Q3 2025 earnings, which saw revenue beat expectations but EPS fall short, though the strong revenue performance was received positively by investors.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
      "source": "Investing.com India",
      "category_within_source": "General",
      "source_domain": "Investing.com India",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.933918"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.821535"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.736238"
        }
      ],
      "overall_sentiment_score": 0.02918,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.333938",
          "ticker_sentiment_score": "0.047848",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Adapthealth director Williams sells $47k in stock",
      "url": "https://www.investing.com/news/insider-trading-news/adapthealth-director-williams-sells-47k-in-stock-93CH-4394480",
      "time_published": "20251206T021044",
      "authors": [
        "By Investing.com"
      ],
      "summary": "AdaptHealth Corp director David Solomon Williams III sold 5,000 shares of the company's stock for $47,150 on December 4, 2025. Following this transaction, Williams directly owns 45,045 shares. This comes after AdaptHealth reported mixed Q3 2025 earnings, beating revenue expectations but missing EPS forecasts.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.930674"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.807470"
        },
        {
          "topic": "finance",
          "relevance_score": "0.649439"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.644061"
        }
      ],
      "overall_sentiment_score": -0.292498,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.079757",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "JPM",
          "relevance_score": "0.540900",
          "ticker_sentiment_score": "-0.455153",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS",
      "url": "https://www.morningstar.com/news/pr-newswire/20251205ny40390/halper-sadeh-llc-encourages-adapthealth-corp-shareholders-to-contact-the-firm-to-discuss-their-rights",
      "time_published": "20251205T203000",
      "authors": [
        "NULL"
      ],
      "summary": "Halper Sadeh LLC, an investor rights law firm, is encouraging long-term shareholders of AdaptHealth Corp. (NASDAQ: AHCO) to contact them regarding potential breaches of fiduciary duties by the company's officers and directors. The firm is offering to investigate and potentially pursue corporate governance reforms, recovery of funds, or other benefits for shareholders on a contingent fee basis. This initiative aims to enhance shareholder value through improved company policies and oversight.",
      "banner_image": "https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg",
      "source": "Morningstar",
      "category_within_source": "General",
      "source_domain": "Morningstar",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.818763"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.628698"
        }
      ],
      "overall_sentiment_score": -0.44514,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.407333",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS",
      "url": "https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-adapthealth-corp-shareholders-to-contact-the-firm-to-discuss-their-rights-302634211.html",
      "time_published": "20251205T153000",
      "authors": [
        "NULL"
      ],
      "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating potential breaches of fiduciary duties by certain officers and directors of AdaptHealth Corp. The firm encourages current long-term AdaptHealth shareholders to contact them to discuss their legal rights and options, which could include seeking corporate governance reforms, the return of funds to the company, or other relief. The firm operates on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees and expenses.",
      "banner_image": "https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg?w=300",
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.824470"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.734817"
        }
      ],
      "overall_sentiment_score": -0.269576,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.284421",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Is the Options Market Predicting a Spike in AdaptHealth Stock?",
      "url": "https://www.tradingview.com/news/zacks:fb75ef810094b:0-is-the-options-market-predicting-a-spike-in-adapthealth-stock/",
      "time_published": "20251205T053140",
      "authors": [
        "Zacks"
      ],
      "summary": "Investors should watch AdaptHealth Corp. (AHCO) due to high implied volatility in its options market, particularly the Dec 19, 2025 $5.00 Call. While this suggests expectations of a significant price movement, AdaptHealth currently holds a Zacks Rank #5 (Strong Sell), with analysts recently lowering earnings estimates. This combination could indicate a developing trading opportunity for options traders to sell premium.",
      "banner_image": "NULL",
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.933099"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.726792"
        }
      ],
      "overall_sentiment_score": -0.234488,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.229342",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. SEC 10-Q Report",
      "url": "https://www.tradingview.com/news/tradingview:18dadce4abc09:0-adapthealth-corp-sec-10-q-report/",
      "time_published": "20251126T145208",
      "authors": [],
      "summary": "AdaptHealth Corp. has released its Form 10-Q report for the third quarter of 2025, detailing stable financial performance with increased net revenue and net income. The report highlights operational efficiency across its key segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. Management expressed optimism for future growth, emphasizing strategic investments and service expansion.",
      "banner_image": null,
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.908013"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.812947"
        }
      ],
      "overall_sentiment_score": 0.397575,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.428343",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. to Participate in Upcoming Investor Conference",
      "url": "https://markets.financialcontent.com/wral/article/bizwire-2025-11-26-adapthealth-corp-to-participate-in-upcoming-investor-conference",
      "time_published": "20251126T083000",
      "authors": [
        "AdaptHealth Corp. via Business Wire"
      ],
      "summary": "AdaptHealth Corp. announced its participation in the BofA Securities Leveraged Finance Conference on December 2, 2025, where they will host a fireside chat. The company, a national leader in healthcare-at-home solutions, will make the webcast available on its investor relations website. AdaptHealth provides services across four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, reaching 4.2 million patients annually across 47 states.",
      "banner_image": null,
      "source": "Markets Financial Content",
      "category_within_source": "General",
      "source_domain": "Markets Financial Content",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.949277"
        },
        {
          "topic": "finance",
          "relevance_score": "0.722353"
        }
      ],
      "overall_sentiment_score": 0.104981,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.132283",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?",
      "url": "https://news.futunn.com/en/post/65300113/is-it-time-to-consider-buying-adapthealth-corp-nasdaq-ahco",
      "time_published": "20251123T203100",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "AdaptHealth Corp. (NASDAQ:AHCO) has seen a 10% share price growth recently but remains potentially undervalued according to a price multiple model comparing its P/E ratio to the industry average. The company shows strong future growth potential with expected profit growth of 98% over the next couple of years, suggesting an optimistic outlook for investors. Current valuation and projected growth indicate it might be an opportune time for investors to consider buying AHCO before its future profit outlook is fully factored into the share price.",
      "banner_image": "https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20251123/0-59389874c2ea857e0c0b1e775b97943a-0-4a171fc8575ee03f8d2b89ef87229459.png/big",
      "source": "\u5bcc\u9014\u725b\u725b",
      "category_within_source": "General",
      "source_domain": "\u5bcc\u9014\u725b\u725b",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.926835"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.824756"
        }
      ],
      "overall_sentiment_score": 0.487639,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.490805",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth (NASDAQ: AHCO) cuts term loan A by $275M, boosting S&P unsecured rating",
      "url": "https://www.stocktitan.net/news/AHCO/adapt-health-corp-announces-upgraded-s-p-global-issue-level-rating-yva1wrqfqr0s.html",
      "time_published": "20251117T195900",
      "authors": [],
      "summary": "AdaptHealth Corp. announced that S&P Global Ratings upgraded its issue-level rating on the company's senior unsecured debt to 'BB-' from 'B+' and revised its recovery rating to '4' from '5'. This upgrade reflects AdaptHealth's $225 million year-to-date prepayment of its senior secured term loan A, and a total reduction of $275 million since the end of Q3 2024, improving its balance sheet and risk profile. The company attributes this to strong free cash flow generation and proceeds from the disposition of non-core assets.",
      "banner_image": null,
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.907089"
        },
        {
          "topic": "finance",
          "relevance_score": "0.829863"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.712584"
        }
      ],
      "overall_sentiment_score": 0.442311,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.440707",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth (AHCO) Profitability Marks Turnaround, Challenging Bearish Valuation Narratives",
      "url": "https://www.sahmcapital.com/news/content/adapthealth-ahco-profitability-marks-turnaround-challenging-bearish-valuation-narratives-2025-11-05",
      "time_published": "20251105T034300",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "AdaptHealth (AHCO) has recently become profitable, with significant shifts in its net profit margin and projected annual earnings growth of 23.1%. A new five-year, $1+ billion contract is expected to drive predictable, recurring revenue, while the company's valuation remains below industry averages and analyst price targets. Analysts foresee expanding net profit margins due to digital automation and improved operating efficiency, despite concerns over debt and industry reimbursement changes.",
      "banner_image": "https://images.simplywall.st/company/18b291b3-d4cf-4d55-9903-e2873feabc72/chart/earnings-and-revenue-history",
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.930032"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.828410"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.932728"
        }
      ],
      "overall_sentiment_score": 0.512466,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.527628",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates",
      "url": "https://finance.yahoo.com/news/adapthealth-corp-ahco-misses-q3-140502830.html",
      "time_published": "20251104T021129",
      "authors": [
        "Zacks Equity Research"
      ],
      "summary": "AdaptHealth Corp. (AHCO) reported Q3 earnings of $0.22 per share, falling short of the Zacks Consensus Estimate of $0.24 per share, despite a year-over-year increase from $0.21. The company's revenues for the quarter were $820.31 million, surpassing the consensus estimate. However, AdaptHealth currently holds a Zacks Rank #5 (Strong Sell) due to unfavorable estimate revisions, indicating potential underperformance in the near future.",
      "banner_image": "NULL",
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.822271"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.708409"
        }
      ],
      "overall_sentiment_score": -0.272257,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.266116",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights",
      "url": "https://www.businesswire.com/news/home/20251024036993/en/Halper-Sadeh-LLC-Encourages-AdaptHealth-Corp.-Shareholders-to-Contact-the-Firm-to-Discuss-Their-Rights",
      "time_published": "20251102T114051",
      "authors": [],
      "summary": "Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential legal rights and options, which could include corporate governance reforms, the return of funds to the company, or other relief. Halper Sadeh LLC represents investors globally and operates on a contingent fee basis.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.707382"
        }
      ],
      "overall_sentiment_score": -0.425219,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.423832",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Trading the Move, Not the Narrative: (AHCO) Edition",
      "url": "https://news.stocktradersdaily.com/news_release/4/Trading_the_Move,_Not_the_Narrative:_AHCO_Edition_101625122402_1760631842.html",
      "time_published": "20251016T122402",
      "authors": [
        "Neal",
        "Thomas H. Kee Jr."
      ],
      "summary": "This article analyzes Adapthealth Corp. (NASDAQ: AHCO) using AI models to provide trading strategies. Key findings indicate stable neutral readings in shorter horizons, a mid-channel oscillation, and an exceptional risk-reward setup. The analysis offers specific entry, target, and stop-loss points for position trading, momentum breakout, and risk hedging strategies.",
      "banner_image": "https://news.stocktradersdaily.com/media/649276_AHCO_graph.jpg",
      "source": "news.stocktradersdaily.com",
      "category_within_source": "General",
      "source_domain": "news.stocktradersdaily.com",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.725860"
        },
        {
          "topic": "technology",
          "relevance_score": "0.420361"
        },
        {
          "topic": "finance",
          "relevance_score": "0.421991"
        }
      ],
      "overall_sentiment_score": 0.041616,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.313414",
          "ticker_sentiment_score": "0.025926",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Announces Third Quarter 2025 Earnings Release Date and Conference Call - Yahoo Finance",
      "url": "https://finance.yahoo.com/news/adapthealth-corp-announces-third-quarter-200500271.html",
      "time_published": "20251013T200500",
      "authors": [
        "Business Wire"
      ],
      "summary": "AdaptHealth Corp. announced its third-quarter 2025 earnings release date as November 4, 2025, before market open, followed by a conference call at 8:30 a.m. ET to discuss financial results and business activities. The company, a national leader in healthcare-at-home solutions, will provide call-in details and webcast registration for interested parties. A replay of the call will be available for six months on their website.",
      "banner_image": null,
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.936149"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.711540"
        },
        {
          "topic": "finance",
          "relevance_score": "0.434932"
        }
      ],
      "overall_sentiment_score": 0.019699,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.348530",
          "ticker_sentiment_score": "0.027341",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Q2 Earnings Show $257M Cash Flow Strength Despite Revenue Dip to $800M",
      "url": "https://www.stocktitan.net/news/AHCO/adapt-health-corp-announces-second-quarter-2025-pi5f19iypylj.html",
      "time_published": "20250805T070100",
      "authors": [],
      "summary": "AdaptHealth announced its Q2 2025 financial results, reporting $800.4 million in net revenue and a year-to-date operating cash flow of $257.5 million. The company updated its full-year 2025 financial guidance, narrowing its net revenue outlook and slightly reducing its Adjusted EBITDA forecast while maintaining its free cash flow projection. AdaptHealth is focusing on driving revenue growth, improving operating efficiency, and reducing debt, highlighted by a new capitated partnership with a major national healthcare system.",
      "banner_image": null,
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.902771"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.748168"
        }
      ],
      "overall_sentiment_score": 0.115321,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.958321",
          "ticker_sentiment_score": "0.102958",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates",
      "url": "https://finance.yahoo.com/news/adapthealth-corp-ahco-lags-q2-121503338.html",
      "time_published": "20250805T053141",
      "authors": [
        "Zacks Equity Research"
      ],
      "summary": "AdaptHealth Corp. (AHCO) reported Q2 earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.15 and significantly lower than $0.21 a year ago. The company's revenues were $800.37 million, also missing the consensus estimate. Following these results, AdaptHealth holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market.",
      "banner_image": "NULL",
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940787"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.702356"
        }
      ],
      "overall_sentiment_score": 0.031668,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.344981",
          "ticker_sentiment_score": "0.017149",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Announces Second Quarter 2025 Results",
      "url": "https://www.tradingview.com/news/tradingview:4fb2d3123bc9c:0-adapthealth-corp-announces-second-quarter-2025-results/",
      "time_published": "20250805T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. announced its financial results for the second quarter ended June 30, 2025, reporting a slight decrease in net revenue and net income compared to the previous year. Despite this, the company highlighted progress in reducing debt and strengthening its financial position, along with a new capitated partnership. AdaptHealth also updated its financial guidance for fiscal year 2025, adjusting net revenue and Adjusted EBITDA expectations while maintaining free cash flow guidance.",
      "banner_image": null,
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.909918"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.723105"
        },
        {
          "topic": "finance",
          "relevance_score": "0.602742"
        }
      ],
      "overall_sentiment_score": 0.045859,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.315110",
          "ticker_sentiment_score": "0.039302",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price",
      "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/insufficient-growth-at-adapthealth-corp-nasdaqahco-hampers-s",
      "time_published": "20250723T000000",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "AdaptHealth Corp.'s low price-to-sales (P/S) ratio of 0.4x is attributed to its insufficient revenue growth compared to the Healthcare industry. While the stock may appear cheap, investors are likely waiting for improved performance, as analyst forecasts project lower revenue growth for AdaptHealth compared to its industry peers. This pessimistic outlook on revenue prospects is identified as the main reason for the depressed share price.",
      "banner_image": null,
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.922768"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.709666"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.633833"
        }
      ],
      "overall_sentiment_score": -0.232875,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.217637",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on",
      "url": "https://www.globenewswire.com/news-release/2025/07/02/3109578/0/en/Important-Notice-to-Long-Term-Shareholders-of-AdaptHealth-Corp-NASDAQ-AHCO-CorMedix-Inc-NASDAQ-CRMD-Napco-Security-Technologies-Inc-NASDAQ-NSSC-and-Virtu-Financial-Inc-NYSE-VIRT-Gr.html",
      "time_published": "20250702T174100",
      "authors": [
        "Grabar Law Office"
      ],
      "summary": "Grabar Law Office is investigating claims on behalf of long-term shareholders of AdaptHealth Corp. (NASDAQ: AHCO), CorMedix Inc. (NASDAQ: CRMD), Napco Security Technologies, Inc. (NASDAQ: NSSC), and Virtu Financial Inc. (NYSE: VIRT). The investigations stem from ongoing securities fraud class actions and other legal developments involving these companies. Shareholders who held stocks prior to specific dates are encouraged to seek corporate reforms and potential incentive awards at no cost.",
      "banner_image": null,
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.730598"
        }
      ],
      "overall_sentiment_score": -0.342968,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.342746",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Earnings call transcript: Adapthealth misses Q2 2025 EPS forecasts, stock dips",
      "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-adapthealth-misses-q2-2025-eps-forecasts-stock-dips-93CH-4170757",
      "time_published": "20250508T122700",
      "authors": [
        "Investing.com"
      ],
      "summary": "AdaptHealth Corp. (AHCO) reported Q2 2025 earnings, missing EPS and revenue forecasts, which led to a 1.76% stock dip in pre-market trading. Despite the shortfall, the company maintains its 2025 revenue guidance and announced a significant new capitated agreement expected to generate over $200 million in annual revenue, strengthening its long-term outlook. AdaptHealth is also leveraging AI and automation to enhance operational efficiency and reduce debt.",
      "banner_image": null,
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.911409"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.745764"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.606196"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.620943"
        }
      ],
      "overall_sentiment_score": -0.208785,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.210129",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth \u2018stays the course\u2019 for Q1",
      "url": "https://www.hmenews.com/article/adapthealth-stays-the-course-for-q1",
      "time_published": "20250506T095300",
      "authors": [
        "HME News Staff"
      ],
      "summary": "AdaptHealth reported Q1 2025 revenue of $777.9 million, a 1.8% decrease year-over-year, with a net loss of $7.2 million. Despite this, the company highlighted progress in debt reduction and improvement in its Diabetes Health segment. AdaptHealth also updated its fiscal year 2025 financial guidance after selling certain incontinence assets.",
      "banner_image": "NULL",
      "source": "HME News",
      "category_within_source": "General",
      "source_domain": "HME News",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.835539"
        }
      ],
      "overall_sentiment_score": 0.04136,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.320834",
          "ticker_sentiment_score": "0.027628",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Russell Schuster named AdaptHealth Corp CCO",
      "url": "https://medicalbuyer.co.in/russell-schuster-named-adapthealth-corp-cco/",
      "time_published": "20241204T000000",
      "authors": [
        "MB Bureau"
      ],
      "summary": "AdaptHealth Corp. has appointed Russell Schuster as its new Chief Commercial Officer, effective December 2nd, 2024. In this pivotal role, Schuster will lead the company's commercial strategy and revenue generation efforts. He brings over 25 years of experience, including a recent tenure as President of Cardinal Health Canada, and is expected to drive top-line growth and strategic execution for AdaptHealth.",
      "banner_image": null,
      "source": "Medical Buyer",
      "category_within_source": "General",
      "source_domain": "Medical Buyer",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.928223"
        },
        {
          "topic": "finance",
          "relevance_score": "0.717848"
        }
      ],
      "overall_sentiment_score": 0.195739,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.321939",
          "ticker_sentiment_score": "0.035096",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "CAH",
          "relevance_score": "0.640213",
          "ticker_sentiment_score": "0.409093",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Names Scott Barnhart as New COO to Drive Growth and Excellence",
      "url": "https://www.mychesco.com/a/news/regional/adapthealth-corp-names-scott-barnhart-as-new-coo-to-drive-growth-and-excellence/",
      "time_published": "20240902T000000",
      "authors": [
        "Timothy Alexander"
      ],
      "summary": "AdaptHealth Corp. (NASDAQ: AHCO) has announced the appointment of Scott Barnhart as Chief Operating Officer, effective September 23, 2024. Barnhart brings over three decades of leadership experience in global operations, including previous roles at Qurate Retail Group and Cardinal Health. This strategic hire aims to enhance AdaptHealth's operational framework, drive organic growth, and ensure continued excellence in patient care.",
      "banner_image": null,
      "source": "MyChesCo",
      "category_within_source": "General",
      "source_domain": "MyChesCo",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.903205"
        },
        {
          "topic": "finance",
          "relevance_score": "0.709339"
        }
      ],
      "overall_sentiment_score": 0.434295,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.427833",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Appoints Scott Barnhart as Chief Operating Officer",
      "url": "https://www.citybiz.co/article/593230/adapthealth-corp-appoints-scott-barnhart-as-chief-operating-officer/",
      "time_published": "20240826T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. announced the appointment of Scott Barnhart as its new Chief Operating Officer, effective September 23, 2024. Barnhart brings over 30 years of global operations leadership experience, including previous roles at Qurate Retail Group and Cardinal Health, which AdaptHealth CEO Suzanne Foster believes will significantly enhance the company's operational excellence and patient care. AdaptHealth is a national provider of patient-centered, healthcare-at-home solutions, serving approximately 4.2 million patients annually across 47 states.",
      "banner_image": null,
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "1.000000"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.711117"
        }
      ],
      "overall_sentiment_score": 0.413087,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.421102",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth Announces Leadership Changes to Board",
      "url": "https://hme-business.com/adapthealth-announces-leadership-changes-to-board/",
      "time_published": "20240709T000000",
      "authors": [
        "Shelby Grebbin"
      ],
      "summary": "AdaptHealth Corp. announced significant leadership changes, including the appointment of Dale Wolf as the new chair of the board, effective July 1, 2024. Josh Parnes will step down as president on August 31, 2024, and from the board on December 31, 2024, following Suzanne Foster's appointment as CEO in May. The company reported a Q1 2024 revenue of $792.5 million, up 6.4% year-over-year, despite a net loss of $2.1 million.",
      "banner_image": null,
      "source": "HME Business",
      "category_within_source": "General",
      "source_domain": "HME Business",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.941019"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.742681"
        }
      ],
      "overall_sentiment_score": 0.193661,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.284024",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "RMD",
          "relevance_score": "0.609269",
          "ticker_sentiment_score": "0.149319",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. (AHCO) Shareholders - L&K, LLP Encourages you to File a Claim Against the Settlement Fund Before Deadline",
      "url": "https://www.kxan.com/business/press-releases/accesswire/881650/adapthealth-corp-ahco-shareholders-lk-llp-encourages-you-to-file-a-claim-against-the-settlement-fund-before-deadline/",
      "time_published": "20240625T133000",
      "authors": [],
      "summary": "Levi & Korsinsky, LLP is informing shareholders of AdaptHealth Corp. (AHCO) about a settlement reached in a class action lawsuit. A $51,000,000 fund is available for eligible class members who purchased or acquired AHCO common stock or options between November 8, 2019, and July 16, 2021. Shareholders must file a claim form by July 15, 2024, to receive a share of the settlement.",
      "banner_image": null,
      "source": "KXAN Austin",
      "category_within_source": "General",
      "source_domain": "KXAN Austin",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.913618"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.721822"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.620571"
        }
      ],
      "overall_sentiment_score": -0.142819,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.125604",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Names HME Vet Suzanne Foster New CEO",
      "url": "https://hme-business.com/adapthealth-names-hme-vet-suzanne-foster-new-ceo/",
      "time_published": "20240423T000000",
      "authors": [
        "Robert Holly"
      ],
      "summary": "AdaptHealth Corp. (Nasdaq: AHCO) has appointed Suzanne Foster as its new CEO, succeeding interim CEO Richard Barasch. Foster brings extensive experience from companies like Danaher Corporation and Cardinal Health at-Home Solutions, and is tasked with leading AdaptHealth's growth in home medical equipment and health-at-home solutions. Barasch will transition to a special advisor role and then step down from the board entirely.",
      "banner_image": null,
      "source": "HME Business",
      "category_within_source": "General",
      "source_domain": "HME Business",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.931563"
        },
        {
          "topic": "finance",
          "relevance_score": "0.712763"
        },
        {
          "topic": "ipo",
          "relevance_score": "0.624988"
        }
      ],
      "overall_sentiment_score": 0.017407,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.341979",
          "ticker_sentiment_score": "0.009652",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Appoints Suzanne Foster as CEO",
      "url": "https://www.citybiz.co/article/544801/adapthealth-appoints-suzanne-foster-as-ceo/",
      "time_published": "20240417T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. has announced the appointment of Suzanne Foster as its new Chief Executive Officer, effective May 20, 2024. Ms. Foster brings over 25 years of healthcare experience, previously serving as President of Beckman Coulter Life Sciences at Danaher Corporation. Richard Barasch, interim CEO, will transition leadership and remain as Chairman of the Board until June 30, 2024, after which he will serve as a Special Advisor to the CEO.",
      "banner_image": null,
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.946016"
        },
        {
          "topic": "finance",
          "relevance_score": "0.643169"
        }
      ],
      "overall_sentiment_score": 0.045707,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "0.336595",
          "ticker_sentiment_score": "0.033956",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Partners With Humana on Value-Based Care",
      "url": "https://www.businesswire.com/news/home/20230511005824/en/AdaptHealth-Corp.-Partners-With-Humana-on-Value-Based-Care",
      "time_published": "20231231T235959",
      "authors": [],
      "summary": "AdaptHealth Corp. has partnered with Humana to become the capitated provider of durable home medical equipment and supplies for Humana Medicare Advantage HMO members in 33 states and the District of Columbia. This value-based agreement covers at least 1.0 million members and aims to improve patient care, reduce administrative costs, and eliminate burdens for patients ordering home medical equipment. The partnership leverages AdaptHealth's extensive national network and focus on technology and in-home service.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.940991"
        },
        {
          "topic": "finance",
          "relevance_score": "0.704711"
        }
      ],
      "overall_sentiment_score": 0.41177,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.470817",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "HUM",
          "relevance_score": "0.945370",
          "ticker_sentiment_score": "0.342932",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AdaptHealth Corp. - AHCO",
      "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-adapthealth-corp---ahco-302010622.html",
      "time_published": "20231210T074500",
      "authors": [],
      "summary": "The Pomerantz Law Firm is investigating potential securities fraud claims against AdaptHealth Corp. (NASDAQ: AHCO) on behalf of its investors. This investigation follows a secondary public offering in January 2021 and a significant stock drop in February 2023 after AdaptHealth announced a fourth-quarter loss and reduced 2023 guidance. The firm specializes in corporate, securities, and antitrust class litigation.",
      "banner_image": null,
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940474"
        },
        {
          "topic": "finance",
          "relevance_score": "0.810499"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.709262"
        }
      ],
      "overall_sentiment_score": -0.638196,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.605397",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "COSTLY MISTAKES: AdaptHealth to Pay Approximately $6MM To Settle TCPA Claim After It Fails to Honor SMS Stop Requests",
      "url": "https://tcpaworld.com/2023/08/24/costly-mistakes-adapthealth-to-pay-approximately-6mm-to-settle-tcpa-claim-after-it-fails-to-honor-sms-stop-requests/",
      "time_published": "20230824T000000",
      "authors": [
        "Puja \"Queenie\" Amin"
      ],
      "summary": "AdaptHealth has agreed to settle a TCPA class action for approximately $6 million after failing to honor \"stop\" requests from consumers for text messages. The settlement structure is unusual, involving direct payments to claimants and a separate sum for plaintiff's lawyers, with a limited release of claims. The case highlights the importance of honoring \"stop\" requests for text messages, even in a changing regulatory landscape, due to TCPA's strict liability.",
      "banner_image": null,
      "source": "TCPAWorld",
      "category_within_source": "General",
      "source_domain": "TCPAWorld",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.848280"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.737968"
        }
      ],
      "overall_sentiment_score": -0.621413,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.624087",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth Appoints Crispin Teufel as Chief Executive Officer",
      "url": "https://www.citybiz.co/article/434328/adapthealth-appoints-crispin-teufel-as-chief-executive-officer/",
      "time_published": "20230627T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. has announced the appointment of Crispin Teufel as its new Chief Executive Officer, effective September 1, 2023. Teufel previously served as CEO of Lincare Holdings Inc., bringing extensive industry experience to AdaptHealth. Richard Barasch, Chairman of the Board, will serve as interim CEO until Teufel assumes the role.",
      "banner_image": null,
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.901083"
        }
      ],
      "overall_sentiment_score": 0.43042,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.410183",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Humana partners with 2 durable medical equipment companies for home care",
      "url": "https://www.fiercehealthcare.com/payers/humana-partners-2-durable-medical-equipment-companies-home-care",
      "time_published": "20230511T155000",
      "authors": [
        "Paige Minemyer"
      ],
      "summary": "Humana has partnered with AdaptHealth Corp. and Rotech Healthcare to provide value-based durable medical equipment (DME) services to its Medicare Advantage HMO members starting July 1. These agreements are part of Humana's broader strategy to expand value-based care into the home, aiming to serve 40% of its Medicare Advantage members by 2025 and streamline DME sourcing. The partnerships are expected to enhance access to home care services and help reduce unnecessary hospitalizations.",
      "banner_image": null,
      "source": "Fierce Healthcare",
      "category_within_source": "General",
      "source_domain": "Fierce Healthcare",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "1.000000"
        }
      ],
      "overall_sentiment_score": 0.306404,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.406694",
          "ticker_sentiment_label": "Bullish"
        },
        {
          "ticker": "HUM",
          "relevance_score": "0.901054",
          "ticker_sentiment_score": "0.335504",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "UNH",
          "relevance_score": "0.647303",
          "ticker_sentiment_score": "0.248778",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth CEO Stephen Griggs to Retire",
      "url": "https://www.citybiz.co/article/414338/adapthealth-ceo-stephen-griggs-to-retire/",
      "time_published": "20230509T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. announced that CEO Stephen Griggs will retire on June 30, 2023, by mutual agreement with the Board of Directors. The Board is actively searching for a successor, with Chairman Richard Barasch prepared to serve as interim CEO if needed. Griggs, who joined AdaptHealth in 2021 following its acquisition of AeroCare Holdings, Inc. which he founded, is credited with key leadership in integrating the companies and navigating significant market challenges.",
      "banner_image": null,
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.902587"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.840221"
        }
      ],
      "overall_sentiment_score": 0.149696,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.126542",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth CEO Stephen Griggs to step down 'by mutual agreement'",
      "url": "https://www.bizjournals.com/philadelphia/news/2023/05/09/adapthealth-ceo-stephen-griggs-plymouth-meeting.html",
      "time_published": "20230509T000000",
      "authors": [
        "John George"
      ],
      "summary": "Stephen Griggs will step down as CEO of AdaptHealth next month by mutual agreement. This announcement follows a previous settlement where AdaptHealth agreed to pay $5.3 million to resolve allegations of submitting false claims for respiratory devices. The company has recently been involved in other significant events, including a large stock offering and a major acquisition.",
      "banner_image": null,
      "source": "The Business Journals",
      "category_within_source": "General",
      "source_domain": "The Business Journals",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.940781"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.746777"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.611312"
        }
      ],
      "overall_sentiment_score": -0.404251,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.417625",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth Corp. Announces First Quarter 2023 Results",
      "url": "https://www.businesswire.com/news/home/20230509005719/en/AdaptHealth-Corp.-Announces-First-Quarter-2023-Results",
      "time_published": "20230509T000000",
      "authors": [],
      "summary": "AdaptHealth Corp. announced its first quarter 2023 financial results, reporting a 5.4% increase in net revenue to $744.6 million, largely driven by strong growth in its Sleep business. Despite a decrease in Adjusted EBITDA compared to the prior year, the company saw a significant increase in cash flow from operations and is implementing a cost management program to achieve its full-year financial goals. Management noted the strong performance of its Sleep and Respiratory businesses, which was partially offset by a decline in its Diabetes segment.",
      "banner_image": null,
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.724296"
        }
      ],
      "overall_sentiment_score": 0.135965,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.141808",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "AdaptHealth Expands to 41K SF at 1185 Commerce in the Bronx",
      "url": "https://commercialobserver.com/2022/06/adapthealth-expands-to-41k-sf-at-1185-commerce-in-the-bronx/",
      "time_published": "20220624T133700",
      "authors": [
        "Mark Hallum"
      ],
      "summary": "AdaptHealth, a provider of at-home medical equipment, has expanded its lease at 1185 Commerce Avenue in the Bronx by 13,256 square feet, now occupying the entire 41,101-square-foot building. The expansion was attributed to the property's ideal location, high ceilings, and expansive outdoor space. AdaptHealth specializes in various medical equipment including respiratory devices, mobility aids, and diabetes treatment supplies.",
      "banner_image": null,
      "source": "Commercial Observer",
      "category_within_source": "General",
      "source_domain": "Commercial Observer",
      "topics": [
        {
          "topic": "real_estate",
          "relevance_score": "0.907761"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.725430"
        }
      ],
      "overall_sentiment_score": 0.396627,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.417990",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth to Participate in Jefferies Healthcare Conference | User | chroniclejournal.com",
      "url": "https://markets.financialcontent.com/chroniclejournal/article/bizwire-2022-6-1-adapthealth-to-participate-in-jefferies-healthcare-conference",
      "time_published": "20220601T155000",
      "authors": [
        "AdaptHealth Corp. via Business Wire"
      ],
      "summary": "AdaptHealth Corp. announced that its President and Director, Josh Parnes, and CFO, Jason Clemens, will participate in a fireside chat at the Jefferies Healthcare Conference. The event is scheduled for Wednesday, June 8, at 10:00 am ET, with a live webcast and replay available on AdaptHealth's investor relations website. AdaptHealth specializes in providing patient-centered healthcare-at-home solutions, including medical equipment and supplies, across all 50 states.",
      "banner_image": null,
      "source": "FinancialContent",
      "category_within_source": "General",
      "source_domain": "FinancialContent",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.929381"
        },
        {
          "topic": "finance",
          "relevance_score": "0.727554"
        }
      ],
      "overall_sentiment_score": 0.19476,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.150022",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "CLASS ACTION UPDATE for AHCO, KPLT and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",
      "url": "https://finance.yahoo.com/news/class-action-ahco-kplt-sava-174500396.html",
      "time_published": "20210921T174500",
      "authors": [],
      "summary": "Levi & Korsinsky, LLP has announced class action lawsuits against AdaptHealth Corp. (AHCO), Katapult Holdings, Inc. (KPLT), and Cassava Sciences, Inc. (SAVA) on behalf of investors. The lawsuits allege that these companies made materially false and/or misleading statements regarding their business operations and financial prospects. Shareholders are encouraged to join the class actions by the specified lead plaintiff deadlines.",
      "banner_image": null,
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.930382"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.720391"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.636099"
        },
        {
          "topic": "technology",
          "relevance_score": "0.612715"
        }
      ],
      "overall_sentiment_score": -0.46651,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.486985",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AdaptHealth Corp. (AHCO)",
      "url": "https://www.globenewswire.com/news-release/2021/09/17/2299257/34548/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-AdaptHealth-Corp-AHCO.html?utm_outm_reach_campaign=Python%2F%2F%2F%2F%2F",
      "time_published": "20210917T130000",
      "authors": [],
      "summary": "Glancy Prongay & Murray LLP is reminding investors of AdaptHealth Corp. (AHCO) about an upcoming September 27, 2021 deadline to file as lead plaintiff in a class action lawsuit. The lawsuit alleges that AdaptHealth misrepresented its organic growth trajectory and overstated its financial prospects, causing investor injury. Investors who acquired AHCO securities between November 11, 2019, and July 16, 2021, may be affected.",
      "banner_image": null,
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.930777"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.708091"
        }
      ],
      "overall_sentiment_score": -0.626397,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.606582",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "AdaptHealth Appoints Stephen Griggs as CEO",
      "url": "https://www.mpo-mag.com/breaking-news/adapthealth-appoints-stephen-griggs-as-ceo/",
      "time_published": "20210830T192654",
      "authors": [
        "Michael Barbella"
      ],
      "summary": "AdaptHealth Corp. has appointed Stephen Griggs as its new CEO, effective immediately. Griggs, who previously served as co-CEO after AdaptHealth's acquisition of AeroCare Holdings Inc. which he founded, takes over after Luke McGee resigned. An independent investigation found no connection between McGee's private activities and the company, and the board expresses full confidence in Griggs' leadership to drive continued growth and strategic objectives.",
      "banner_image": null,
      "source": "Medical Product Outsourcing",
      "category_within_source": "General",
      "source_domain": "Medical Product Outsourcing",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.930895"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.810008"
        }
      ],
      "overall_sentiment_score": 0.421163,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.405099",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "AdaptHealth appoints lone CEO, updates investigation of former co-chief executive",
      "url": "https://www.bizjournals.com/philadelphia/news/2021/06/15/adapthealth-plymouth-meeting-medical-equipment-ceo.html",
      "time_published": "20210615T192654",
      "authors": [
        "John George"
      ],
      "summary": "Plymouth Meeting-based AdaptHealth has appointed Steve Griggs as its lone CEO. This appointment comes as the company continues its investigation into its former co-chief executive, who has been charged with alleged tax fraud in Denmark. The article also lists several related past news items concerning AdaptHealth's stock offerings and acquisitions.",
      "banner_image": null,
      "source": "The Business Journals",
      "category_within_source": "General",
      "source_domain": "The Business Journals",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.849925"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.729670"
        },
        {
          "topic": "finance",
          "relevance_score": "0.643136"
        },
        {
          "topic": "economy_fiscal",
          "relevance_score": "0.642065"
        }
      ],
      "overall_sentiment_score": 0.103416,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "AHCO",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.122161",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    }
  ]
}